30 studies found for:    Open Studies | "Gout"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Gout"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
2 Not yet recruiting Colchicine Or Naproxen Treatment for ACute gouT
Condition: Gout
Interventions: Drug: Low-dose colchicine;   Drug: Naproxen
3 Recruiting DECT Study in Allopurinol-Treated Gout Patients
Condition: Gout
Intervention: Procedure: DECT scan
4 Recruiting Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients
Conditions: Gout;   Hyperuricemia
Interventions: Drug: URC102 0.25mg;   Drug: URC102 0.5mg;   Drug: URC102 1.0mg;   Drug: URC102 2.0mg;   Drug: placebo
5 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Syndrome;   Endothelial Dysfunction;   Hyperuricemia;   Gout;   Metabolic Syndrome
Intervention:
6 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout
Condition: Gout
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
7 Recruiting Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout
Condition: Gout
Interventions: Drug: Bucillamine;   Drug: Colchicine
8 Recruiting Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment
Conditions: Gout;   Moderate Renal Impairment
Interventions: Drug: Febuxostat IR;   Drug: Febuxostat XR;   Drug: Febuxostat placebo;   Drug: Colchicine;   Drug: Naproxen;   Drug: Lansoprazole
9 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
10 Recruiting A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: AC-201;   Drug: Febuxostat
11 Recruiting Elastography as Gouty Arthropathy Outcome (EGO)
Condition: Gout
Intervention:
12 Recruiting Genetics of Hyperuricemia Therapy in Hmong
Condition: Hyperuricemia, Gout
Intervention: Drug: Allopurinol
13 Recruiting Rheumatology Informatics System for Effectiveness
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Gout
Intervention:
14 Recruiting Impact of Unapproved Drug Initiative on Colchicine Use
Condition: Gout
Intervention:
15 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
16 Recruiting Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Condition: Gouty Arthritis
Interventions: Drug: Canakinumab, ACZ885;   Drug: Triamcinolone acetonide
17 Recruiting Optimal Administration of Allopurinol in Dialysis Patients
Conditions: Gout;   Renal Insufficiency
Intervention: Drug: Allopurinol
18 Recruiting Safety and Pharmacodynamics of SEL-037 (Pegsiticase) in Subjects With Elevated Blood Uric Acid Levels
Condition: Gout
Intervention: Biological: SEL-037 (pegsiticase)
19 Not yet recruiting Pharmacogenetics of SGLT2 Inhibitors
Conditions: Diabetes Mellitus;   Gout;   Hyperuricemia
Intervention: Drug: Canagliflozin
20 Not yet recruiting Prospective Analgesic Compound Efficacy (PACE) Study
Conditions: Arthritis;   Tendonitis;   Gout;   Radiculopathy;   Muscle Spasms;   Synovitis;   Migraine;   Headache
Interventions: Drug: baclofen 2%;   Drug: Bupivacaine hydrochloride 1%;   Drug: Cyclobenzaprine hydrochloride 2%;   Drug: Diclofenac Sodium 3%;   Drug: Flurbiprofen 10%;   Drug: Gabapentin 6%;   Drug: Ketamine 10%;   Drug: Lidocaine 2%;   Drug: Prilocaine 2.5%;   Drug: Meloxicam 0.09%;   Drug: Sumatriptan 5%;   Drug: Tizanidine 0.1%;   Drug: Topiramate 2.5%;   Drug: Capsaicin, USP 0.0375%;   Drug: Menthol, NF 5.00 %

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years